Donald M Cannon
Affiliation: University of Wisconsin
- Locoregional recurrence following accelerated partial breast irradiation for early-stage invasive breast cancer: significance of estrogen receptor status and other pathological variablesDonald M Cannon
Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
Ann Surg Oncol 20:3446-52. 2013..Published findings to date have not been consistent. More data are needed as these risk factors continue to be defined...
- A multi-institution evaluation of deformable image registration algorithms for automatic organ delineation in adaptive head and neck radiotherapyNicholas Hardcastle
Department of Human Oncology, University of Wisconsin Madison, Madison, WI, USA
Radiat Oncol 7:90. 2012..This requires regions of interest (ROIs) to be defined using the most recent imaging data. This study investigates the clinical utility of using deformable image registration (DIR) to automatically propagate ROIs...
- Increased local failure risk with prolonged radiation treatment time in head and neck cancer treated with concurrent chemotherapyDonald M Cannon
Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
Head Neck 36:1120-5. 2014..However, the significance of prolonged RTT with concurrent chemotherapy is less clear...
- Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancerDonald M Cannon
Donald M Cannon, Pranshu Mohindra, Søren M Bentzen, Anne M Traynor, Richard J Chappell, University of Wisconsin School of Medicine and Public Health, Madison, WI Minesh P Mehta, University of Maryland, Baltimore, MD Jarrod B Adkison, Southeast Alabama Medical Center, Dothan, AL Deepak Khuntia, Varian Medical Systems, Palo Alto, CA Wolfgang A Tomé, Albert Einstein College of Medicine, Bronx, NY George M Cannon, Intermountain Medical Center, Salt Lake City, UT Ranjini Tolakanahalli, Juravinski Cancer Center, Hamilton, Canada
J Clin Oncol 31:4343-8. 2013..The maximum-tolerated dose (MTD) with dose-escalated hypofractionation has not been adequately defined...